EuBiologics Wins USD 7.89 Million UNICEF Cholera Vaccine Order

• EuBiologics secured a KRW 10.46 billion contract from UNICEF to supply Euvichol-S oral cholera vaccine for Mozambique.
• The order represents 7.01% of the company's latest annual revenue.
• The contract was signed Oct. 23, 2026, with supply running through Jan. 31, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EuBiologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026900136), on October 26, 2026, and is solely responsible for the information contained therein.